Macrovascular Complications of Type 2 Diabetes Mellitus.


Journal

Current vascular pharmacology
ISSN: 1875-6212
Titre abrégé: Curr Vasc Pharmacol
Pays: United Arab Emirates
ID NLM: 101157208

Informations de publication

Date de publication:
2020
Historique:
received: 11 11 2018
revised: 02 12 2018
accepted: 09 12 2018
pubmed: 10 4 2019
medline: 29 9 2020
entrez: 10 4 2019
Statut: ppublish

Résumé

Type 2 diabetes mellitus (T2DM) has emerged as a pandemic. It has different complications, both microvascular and macrovascular. The purpose of this review is to summarize the different types of macrovascular complications associated with T2DM. A comprehensive review of the literature was performed to identify clinical studies, which determine the macrovascular complications associated with T2DM. Macrovascular complications of T2DM include coronary heart disease, cardiomyopathy, arrhythmias and sudden death, cerebrovascular disease and peripheral artery disease. Cardiovascular disease is the primary cause of death in diabetic patients. Many clinical studies have shown a connection between T2DM and vascular disease, but almost always other risk factors are present in diabetic patients, such as hypertension, obesity and dyslipidaemia. T2DM causes a variety of macrovascular complications through different pathogenetic pathways that include hyperglycaemia and insulin resistance. The association between T2DM and cardiovascular disease is clear, but we need more clinical studies in order to identify the pure effect of T2DM.

Sections du résumé

BACKGROUND
Type 2 diabetes mellitus (T2DM) has emerged as a pandemic. It has different complications, both microvascular and macrovascular.
OBJECTIVE
The purpose of this review is to summarize the different types of macrovascular complications associated with T2DM.
METHODS
A comprehensive review of the literature was performed to identify clinical studies, which determine the macrovascular complications associated with T2DM.
RESULTS
Macrovascular complications of T2DM include coronary heart disease, cardiomyopathy, arrhythmias and sudden death, cerebrovascular disease and peripheral artery disease. Cardiovascular disease is the primary cause of death in diabetic patients. Many clinical studies have shown a connection between T2DM and vascular disease, but almost always other risk factors are present in diabetic patients, such as hypertension, obesity and dyslipidaemia.
CONCLUSION
T2DM causes a variety of macrovascular complications through different pathogenetic pathways that include hyperglycaemia and insulin resistance. The association between T2DM and cardiovascular disease is clear, but we need more clinical studies in order to identify the pure effect of T2DM.

Identifiants

pubmed: 30961498
pii: CVP-EPUB-97859
doi: 10.2174/1570161117666190405165151
doi:

Types de publication

Journal Article Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

110-116

Informations de copyright

Copyright© Bentham Science Publishers; For any queries, please email at epub@benthamscience.net.

Auteurs

Margus Viigimaa (M)

Centre of Cardiology, North Estonia Medical Centre, Tallinn, Estonia; Institute of Health Technologies, Tallinn University of Technology, Tallinn, Estonia.

Alexandros Sachinidis (A)

2nd Propedeutic Department of Internal Medicine, Aristotle University, Thessaloniki, Greece.

Maria Toumpourleka (M)

2nd Propedeutic Department of Internal Medicine, Aristotle University, Thessaloniki, Greece.

Konstantinos Koutsampasopoulos (K)

2nd Propedeutic Department of Internal Medicine, Aristotle University, Thessaloniki, Greece.

Signe Alliksoo (S)

Centre of Cardiology, North Estonia Medical Centre, Tallinn, Estonia; Institute of Health Technologies, Tallinn University of Technology, Tallinn, Estonia.

Tiina Titma (T)

Centre of Cardiology, North Estonia Medical Centre, Tallinn, Estonia; Institute of Health Technologies, Tallinn University of Technology, Tallinn, Estonia.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH